Galcanezumab may effectively Alleviate Menstrual Migraine: Post-hoc Analysis Josepha James12 Jun 2021 9:00 AM ISTGalcanezumab, a humanized monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated significant effectiveness in patients with...
Autologous adipose injection provides shoulder pain relief for wheelchair users with SCI: Study Medha Baranwal12 Jun 2021 9:00 AM ISTUSA: Micro-fragmented adipose tissue (MFAT) injection has lasting pain-relief effects for rotator cuff disease in wheelchair users with spinal cord...
Researchers use 7T MRI for studying SCD impact on brain Hina Zahid11 Jun 2021 9:00 AM ISTThe findings support and extend previous reports of reduced hippocampal volume in SCD patients but provide more insights on the specific hippocampal...
Continuing Seizure Meds Unnecessary in acute symptomatic neonatal seizures Dr Kartikeya Kohli10 Jun 2021 6:30 PM ISTAcute symptomatic neonatal seizures typically remit within 72 hours, infants often have antiseizure medications (ASMs) maintained for months to years...
Rimegepant and Zavegepant Show Promising Results for Treatment of Migraine Josepha James10 Jun 2021 9:00 AM ISTNurtec ODT (rimegepant) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a quick-dissolve ODT...
Preeclampsia during pregnancy increases stroke risk later in life Hina Zahid9 Jun 2021 9:00 AM ISTWomen who have preeclampsia during pregnancy are at least three times more likely to have strokes later in life than women who do not have a history...
Earlier ECMO beneficial for patients with refractory cardiogenic shock: Study Medha Baranwal9 Jun 2021 9:00 AM ISTSeoul, Korea: Earlier extracorporeal membrane oxygenation (ECMO) support improves clinical outcomes in patients with refractory cardiogenic shock...
Neither CABG nor PCI impact post-procedure cognitive decline risk: JAMA Medha Baranwal8 Jun 2021 4:00 PM ISTUSA: The type of revascularization procedure (CABG or PCI) did not impact the rate of memory decline in older adults undergoing coronary...
Alzheimer's drug Aduhelm receives FDA's accelerated approval Hina Zahid8 Jun 2021 10:32 AM ISTUSA: Aduhelm (aducanumab) has received the US FDA's accelerated approval for the treatment of Alzheimer's disease. Aduhelm was approved using...
Pain medication use may increase falls risk in patients with cognitive impairment: Study Medha Baranwal8 Jun 2021 9:00 AM ISTThese results support that the risk of falls associated with pain medication is elevated among those with higher levels of cognitive impairment.USA:...
Initiating rhythm control early lowers CV risk in recently diagnosed AF patients: Study Medha Baranwal7 Jun 2021 3:30 PM ISTKorea: Early initiation of rhythm control treatment in patients with recently diagnosed atrial fibrillation (AF) lowers the risk of adverse CV...
Celecoxib Oral Solution Relieves Migraine Pain and Improves Other Symptoms MD Bureau7 Jun 2021 9:15 AM ISTNonsteroidal anti-inflammatory drugs (NSAIDs) are effective and widely used for migraine, but gastrointestinal tolerability and safety limit usage by...
